secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001493152-25-011305
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa shareholders elect all six directors and approve warrant share issuance at 2025 annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected: Justin Yorke, George Ng, Khoso Baluch, James Neal, Geraldine Pannu, Dr. David Young.
- Proposal to issue shares upon exercise of Series A and B warrants approved with 1,646,114 for, 275,707 against, 24,613 abstain.
- Ratification of Cherry Bekaert, LLP as independent auditor for FY2025 passed with 3,752,298 for, 166,735 against.
- Advisory vote on executive compensation approved: 1,704,544 for, 224,727 against, 17,163 abstain.
- Meeting held July 18, 2025; broker non-votes on director and other proposals totaled 2,035,053 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225011305/0001493152-25-011305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225011305/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer